303 followers
RT @FrontImmunol: New Research: CD44v6, STn & O-GD2: promising tumor associated antigens paving the way for new targeted cancer therapies:β¦
RT @FrontImmunol: New Research: CD44v6, STn & O-GD2: promising tumor associated antigens paving the way for new targeted cancer therapies:β¦
New Research: CD44v6, STn & O-GD2: promising tumor associated antigens paving the way for new targeted cancer therapies: Targeted therapies are the state of the art in oncology today, and every year new Tumor-associated antigens (TAAs) are⦠#immunology